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Abstract 
People who take analgesic drugs frequently may be at increased risk of end-stage renal disease [ESRD], but the 
extent of this risk remains unclear. Purpose: To investigate the relationship between non-steroidal anti-
inflammatory drugs[NSAIDs] and kidney failure and to confirm the effect NSAIDs and kidney failure. We 
studied 424 persons(298 patient 166 male and 132  female)treated for ESRD of different ages from Hail region 
and 126 healthy person(23male and 103 female) . The study done by questionnaire, we asked them about their 
past use of medications containing paracetamol, aspirin, and others non-steroidal drugs. For each analgesic if it 
was taken routinely, as needed, and for more than 1 year or less. Heavier acetaminophen (paracetamol) use was 
associated with an increased risk of ESRD. In the study population we found that 52.59%   of sick persons used 
paracetamol  and 17.69% not used it. Also we found that 28.77%   of sick persons used aspirin and 41.51% not 
used it. In addition to that we found that 34.43%  of sick persons used  other NSAIDs  and 35.85%  not used 
them.  
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16.51%of sick person confirmed that they had renal failure due to drugs, 49.53 %said no and 4.25 not answered. 
14.39 % of  healthy  person confirmed that drugs caused renal failure  , 14.86%  said no and 0.4% not answered 
using SPSS analysis. People who often taken acetaminophen were associated with an increased risk of ESRD 
more than those often take aspirin or other NSAIDs.  
Keywords: Kidney; failure; NSAIDs; acetaminophen. 
1. Introduction 
1.1. Acute renal failure [ARF] 
ARF is characterized clinically by an abrupt decrease in renal function over a period of hours to days, resulting 
in the accumulation of nitrogenous waste products [azotemia] and the inability to maintain and regulate fluid, 
electrolyte, and acid–base balance [1]. 
 1. 2.Chronic kidney disease [CKD] 
This is often not reversible and describes the continuum of kidney dysfunction from early to late-stage disease 
[2]. 
Estimated glomerular filtration rates [eGFR] range from 90 mL/minute/1.73 m2 in the early stages to 15 
mL/minute/1.73 m2 in the late stages of disease. The most severe stage occurs when the eGFR is less than 15 
mL/minute/1.73 m2 and is known as end-stage renal disease [ESRD] [2].   Patients with ESRD require renal 
replacement therapy in the form of dialysis or transplantation to sustain life. 
The presence of protein in the urine [defined as proteinuria, albuminuria, or microalbuminuria based on protein 
type and amount] is an early and sensitive marker of kidney damage. 
  1.3. Actions and pathophysiological role of prostaglandins [PGs] on kidney 
 PGE2 and PGI2 increase water and K+ excretion and have a diuretic effect. PGI2,  PGE2 and  PGD2 evoke 
release of  renin [3]. 
 1.4 .The objective of this study  
To investigate the relationship between NSAIDs and kidney failure and to confirm the effect  of NSAIDs and 
kidney failure. 
2. Literature review 
Analgesic nephropathy was first described in the 1950s [4]. In patients on long term NSAIDs without acute or 
chronic renal failure, subclinical renal dysfunction such as reduced creatinine clearance and impaired urine 
concentrating ability has been shown to be present.  This dysfunction is reversible on withdrawal of NSAIDs. 
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Even with a wide range of NSAIDs at our disposal, a renal safe NSAID is yet to be discovered [5]. 
There was  previous  study  for  causes  of  chronic kidney disease in 300  patients in Hail  region and they 
found that 23%  of this population  screening  was  due to hypertension and diabetes .This mean that  people in 
Hail region  are of high risk if they use NSAIDs and may be precipitating factor of renal failure [6]. 
2.1. Non-steroidal anti-inflammatory drugs [NSAIDs] 
NSAIDs are used as pain relievers, reduce inflammation and lower fevers. They prevent blood from clotting. 
However; they have adverse effects that can develop  an ulcer. They also may interfere with kidney function [3]. 
The pharmacological action of NSAIDs is due to reducing the production of prostaglandins   [PGs] which are 
chemicals that promote inflammation, pain, and fever.  
Ingestion of 15 g of acetaminophen may be fatal, death being caused by severe hepatotoxicity [7]. Recent data 
also implicate acetaminophen in rare cases of renal damage without hepatic damage even after usual doses of 
acetaminophen [7].  
At the usual dosage, aspirin's renal toxicity occur less frequently [7].Other non-selective cyclooxygenase 
inhibitors include ibuprofen, diclofenac, indomethacin, ketoprofen and mefenamic acid. Selective COX-2 
inhibitors are contraindicated in patients with severe renal insufficiency [COX-2 is constitutively active in the 
kidney].  
3. Materials and methods 
3.1. Material 
This study was done by questionnaire which was developed by the supervisors and students.  
3.1.1. Study participants 
We studied 424 person, 189 male and 235female .298 patients treated for ESRD of male and female of different 
ages and different nationalities (Saudi Arabi 293, Sudan 3،Jordan 2) and 126 healthy person male and female. 
3.1.2. Data collections 
The interviewer explained to participants the objective of the study and asked standards questions. The study 
participant were interviewed separately in the hospitals (King Khalid hospital(236),Al-Shamli hospital(9),Al-
Ghazalah hospital(3) , Moqaq hospital(20) and Baqa’ hospital(30)  approximately for 15minutes about their part 
use of medication containing paracetamol  , aspirin  and other NSAIDs for life time exposure. For each 
analgesic drug the average use [in pills per year] and the cumulative intake (in pills) examined for an association 
with ESRD. The case patient had to have ESRD and had to have started long term dialysis between 5 months to 
7 years in comparison with 126 healthy person male and female .  
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3.2. Statistical analysis  
The observations for each drug were done  using SPSS(cross tabulation and Chi-Square (X 2) statistical  
Analysis, Phi and cramer, s V) was used to compare the drugs  used  by the sick and healthy persons  and P 
values less than 0.05 were considered significant. . 
4. Results 
This study was done in Saudi Arabia in Hail region and we found that many patients using NSAIDs, 
paracetamol and aspirin thought that these drugs caused renal failure.  
A majority of studies participants that taken analgesics drugs either at needed or continuously. The survey 
covered 298 patient and 126 healthy as shown in table 1, the result shown below according to SPSS analysis 
(cross tabulation and Chi-Square (X 2) statistical analysis )  . 
Table 1: The population frequency of distribution in comparison to idea of causes of renal failure (n= 424) 
Patterns Frequency/percent
age  
  
  
 n (%) 
Mean 
 
  
Standard 
error of 
mean 
Standard 
deviation 
P-value 
1.Sex  
 
 1.55 0.024 0.498 P<0.05 
Male 189(44.6%)     
Female  235(55.4%)     
2.Age  1.3 0.022 0.461 P<.001 
10-30 295(69.6%)     
31-60 129(30.4%)     
    3.Status  1.3 0.022 0.458 P<0.001 
Sick 298(70.3%)     
Healthy 126(29.7%)     
 
4.1. Effect of drugs and renal failure 
In this study we found that 16.51% of sick persons confirmed that there was relationship  between intake of  
analgesic drugs   and  the causes of renal failure ,49.53% said no and 4.25%not answered .For healthy 14.39% 
said yes ,14.86 said no and 0.4% not answered . 
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4.2. Effect of paracetamol and renal failure 
In this study   we found that 52.59%  of sick persons  confirmed the use of paracetamol and 17.69% not used  it. 
For healthy persons 15.09% used paracetamol and 14.62% not used it.  
For the use of paracetamol, the percentage of sick persons was 52.59% , who took  it continuously was 14.62 % 
,  who took it at need was 38.44% and 17.22% not answered, in a dose of one tablet was 33.02%,2 tablets was 
12.50% and more than 2 tablets was  5.66% and 19.1% not answered,  in a duration of less than 6month was 
20.05% , less than one year was 4.7% and more than one year was 28.07%.and 17.45% not answered as shown 
in figures 1,2 ,3and 4(P < 0.001) . 
For healthy person 2.36% used it continuously,13.44% when need  and 13.92% not answered  in a  dose of one 
tablet was  6.6% ,2tablet was  7.08% and more than 2 tablet  was   1.18%   and 14.86% not answered in a 
duration of less than 6month was 6.6% , less than one year was 2.36% and more than one year was 5.9%  and 
14.68% not answered as shown in figures 1,2 ,3and 4(P < 0.001) . 
 
Figure 1: Intake of paracetamol by sick persons with ESRD and healthy persons 
  
Figure 2: Intake of paracetamol when needed or continuous by sick persons with ESRD and healthy 
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Figure 3: Intake of paracetamol doses per day by sick persons with ESRD and healthy persons 
 
Figure4: Intake of paracetamol doses duration by sick persons with ESRD and healthy persons 
Values were expressed as  frequency percentages  P < 0.001** * highly significant difference from healthy  
4.3. Effect of aspirin and renal  failure 
For the use of aspirin in this study 29.77%  of sick person  confirmed that used it, 41.51% not used it .  
For healthy persons  5.9% used it ,23.58%not used it and 0.24% not answered.  
For the use of aspirin  the percentage of sick persons was 29.77%, who took  it continuously  was 18.63%,who 
took it at need was 10.61 %  and 41.04% not answered, in a dose of one tablet was 22.64%, 2 tablets was 2.59% 
and more than 2 tablets was  2.12% and 42.92% not answered,  in a duration of less than 6month was 5.44% , 
less than one year was 5.67% and more than one year was 17.73%.and 41.37% not answered as shown in figures 
5,6,7 and 8( P < 0.001) . 
For healthy person 3.54% used it continuously, 3.07% when need  and 23.11% not answered  in a  dose of one 
tablet was  3.77% ,2tablet was  0.94% and more than 2 tablet  was   0.4%   and 24.53% not answered, in a 
duration of less than 6month was 2.36% , less than one year was 0.71% and more than one year was 2.13%  and 
24.59% not answered as shown in figures 5,6 ,7 and 8( P < 0.001) . 
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Figure 5: Intake of aspirin by sick persons with ESRD and healthy persons 
Values were expressed as  frequency percentages  P < 0.001** * highly significant difference from healthy  
 
Figure 6: Intake of aspirin when needed or continuous by sick persons with ESRD and healthy persons 
 
Figure 7: Intake of aspirin doses per day by sick persons with ESRD and healthy persons 
Values were expressed as frequency percentages  P < 0.001** * highly significant difference from healthy 
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Values were expressed as  frequency percentages  P < 0.001** * highly significant difference from healthy  
 
Figure 8: Intake of aspirin doses  duration by sick persons with ESRD and healthy persons 
Values were expressed as  frequency percentages  P < 0.001** * highly significant difference from healthy  
4.4. Effect of other NSAIDs 
Also  for NSAIDs users we  found that 34.43%  of sick persons used  other NSAIDs  , 20.28% was take them  
continuously  and 14.39% was take them  at needed and 35.61% not answered in a dose of  one tablet was  
20.99%, 2  tablets was  8.02%, for more than two tablets was 4.25%  and 37.03% not answered   in a duration of 
less than sixth months was  9.67%, for less than one year  was 3.5%  and for  more than one year 20.75% and 
36.32% not answered as shown in figures 9,10( P < 0.05  ) and 11 ( P < 0.01  ). For healthy person 4.95% used it 
continuously, 8.73% when need  and 16.04% not answered  in a  dose of one tablet was  5.42% ,2tablet was 
4.25% and more than 2 tablet  was   1.89%   and 18.16% not answered, in a duration of less than 6month was 
6.84% , less than one year was 0.71% and more than one year was 4.48%  and 17.69% not answered as shown 
in figures  9,10( P < 0.05 ) and 11  ( P < 0.01  ). 
 
Figure 9: Intake  of other NSAIDS  when needed or continuous by sick persons with ESRD and healthy 
persons.Values were expressed as  frequency percentages  P < 0.05*  significant difference from healthy 
Values were expressed as  frequency percentages  P < 0.05*  significant difference from healthy 
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Figure 10: Intake  of other NSAIDS  doses per day by sick persons with ESRD and healthy persons 
 
Figure 11: Intake  of other NSAIDS  doses duration by sick persons with ESRD and healthy persons 
Values were expressed as  frequency percentages  P < 0.01**  significant difference from healthy  
5. Discussion  
Nephrotoxicity has been observed for all of the NSAIDS and may be due, in part, to interference with the 
autoregulation of renal blood flow, which is modulated by prostaglandins. 
At the therapeutic doses, acetaminophen is considered a safe drug. However, it can cause hepatic necrosis, 
nephrotoxicity, extrahepatic lesions, and even death in humans and experimental animals when taken in 
overdose [8, 9].  
The results in this study revealed that aspirin, acetaminophen and other NSAIDs caused renal failure when used 
regularly in some patients and this confirmed by the previous findings of [10] who studies 716 patient treated 
for ESRD and stated that heavier doses of acetaminophen use associated with an increased risk of ESRD in a 
dose dependent fashion. 
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Although paracetamol has apparent COX-2 inhibitory activity [11], it is widely regarded as being safe in 
patients with risk factors for renal impairment in contrast to patients taking NSAIDs. Experimental proof of this 
concept is scanty but NSAIDs decreased GFR to a greater extent than placebo or paracetamol in a trial involving 
stressed kidneys [low sodium diet, dehydration and exercise] [12], and immediately after surgery in elderly 
patients [13].  The renal safety of paracetamol is also indicated by two studies ﬁnding no increase in the risk of 
hospitalization for heart failure [14] and no worsening of renal function in patients with grades 4–5 kidney 
disease [15]. 
Both are conditions in which NSAIDs are expected to worsen renal function. Conversely, in an epidemiological 
study, [16] reported that paracetamol exacerbated the development of chronic renal failure, although bias could 
not be excluded in this population study. However all NSAIDs may not  have the  same    renal effect .Similarly,  
ibuprofen depressed renal function to a greater extent than paracetamol during surgery on sodium-depleted, 
anaes thetised dogs [17].  
Peripheral oedema was also less common in a clinical trial comparing paracetamol and naproxen [18]. 
Both classes of NSAIDs have been associated with increase in blood pressure [19], more so in patients treated 
for hypertension than normotensive individuals [20].   
6. Conclusion 
On the light of the present study we found that 52.59%   of sick persons  used paracetamol  , 34.43%  of sick 
persons used  other NSAIDs   and 28.77%   of sick persons  used aspirin. 16.51%of sick  person confirmed that 
they had renal failure due to drugs and 14.39 % of  healthy  person  confirmed that drugs caused renal failure  
,using SPSS analysis. People who often taken acetaminophen were associated with an increased risk of ESRD 
more than those often take aspirin or other NSAIDs .  
So there is strong association between renal failure, paracetamol, NSAIDs and aspirin. So our result is concur 
with the Previous  research  suggest that NSAIDs cause renal damage in persons with renal insufficiency  by 
lowering GFR  through  an   anti-prostaglandins effects. 
7. Constraints and limitations 
The collection of large numbers of patients with ESRD  of  the study participant from different areas is   difficult 
and  require long  time  and the time of session of   dialysis  for most patients at night. Also some patients don’t 
respond easily. 
8. Recommendations 
Further study needed with large numbers of patients for more nephrotoxic drugs from NSAIDs to confirm the 
risk of kidney failure and to be more specific because not all NSAIDs have the same renal effect. 
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